Related Experiment Video
Updated: Oct 22, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Gene expression profiling in melanoma: A view from the clinic
S M Bollard1, C Casalou2, S M Potter1
1School of Medicine & UCD Conway Institute of Biomolecular & Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland; Department of Plastic & Reconstructive Surgery, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland; Mater Melanoma Research Group, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland.
Gene Expression Profiling (GEP) offers personalized melanoma treatment by analyzing tumor molecular signatures. This approach can improve early detection and risk stratification, addressing limitations in current melanoma diagnostics.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Melanoma treatment advanced with targeted therapies and immunotherapies.
- Current methods for early melanoma detection and risk stratification are insufficient.
- Breslow Thickness is the primary prognostic indicator, but limitations exist.
Purpose of the Study:
- To describe the current use and clinical impact of Gene Expression Profiling (GEP) in melanoma.
- To explore the potential roles of GEP in addressing clinical challenges in melanoma treatment.
- To identify future research directions for GEP in melanoma management.
Main Methods:
- Review of current clinical applications of Gene Expression Profiling (GEP).
- Analysis of the impact of GEP on melanoma patient management.
- Discussion of GEP's potential in guiding treatment decisions.
Main Results:
- Gene Expression Profiling (GEP) is increasingly available for personalized melanoma care.
- GEP has shown success in other cancers like breast and prostate cancer.
- GEP's widespread clinical use in melanoma is still emerging.
Conclusions:
- GEP holds significant potential to enhance melanoma risk stratification and treatment decisions.
- Further research is needed to fully integrate GEP into routine melanoma clinical practice.
- GEP can aid in decisions regarding adjuvant therapy, sentinel lymph node biopsy, and surgical resection.

